Showing 1 - 2 of 2 trials – Showing only trials currently accepting patients
-
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery
Stanford is currently accepting patients for this trial. -
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Stanford is currently accepting patients for this trial.